![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, March 18, 2017 9:52:50 PM
The trouble began when the FDA felt that Pfizer wasn't correcting the problems either quick enough or to the FDA's satisfaction, that's why the warning letter was issued.
If the FDA felt the problems were being addressed properly they never would have issued the warning letter and there would be no problem.
Pfizer has a lot of explaining to do because they were previously cited for some of the exact same problems years ago and if they did rectify them years ago why are the problems back.
I never believed that Sandoz/ Momenta was going to launch 'at-risk' in February which was the general board consensus, but I did think they'd launch this year. Maybe not after this crap.
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM